Tag: research
-
3 Cancer Breakthroughs from ASCO 2026 That Could Change Patient Care
And What is ASCO Anyway??? (It’s the American Society of Clinical Oncology.) 1. A New Targeted Drug Doubled Survival in Metastatic Pancreatic Cancer This one is exciting. One of the most talked-about presentations at ASCO 2026 involved the investigational drug daraxonrasib for advanced pancreatic cancer. Researchers have been trying to find something that would block…
-
GLP-1 RAs and HR+/HER2- Breast Cancer
Some pretty exciting research has come about regarding GLP-1 receptor agonists (think drugs like Ozempic or Wegovy). Researchers studying large populations of women found that GLP-1 receptor agonists were associated with a lower incidence of HR+/HER2− breast cancer, improved overall survival, and lower recurrence rates within certain breast cancer populations. GLP-1 stands for “glucagon-like peptide-1”…
Writing RN 